• Premium
  • About
  • Partner Pages
  • Support & FAQs
  • Log in

The Mandarin

The Mandarin
The Mandarin
  • Premium
  • Careers
    • Search SES Jobs
    • Career Advice
  • News
  • Editors’ Picks
  • Portfolios
  • Events
  • Resource library
  • Small Logo
  • Premium
  • Careers
    • Search SES Jobs
    • Career Advice
  • News
  • Editors’ Picks
  • Portfolios
  • Events
  • Resource library

Partner Content

Home Portfolio Economy & Industry What will it take to make Australia a global pharma player?

What will it take to make Australia a global pharma player?

By Tom Burton

June 7, 2017

Test Tubes And Dropper – Scientific Experiment

Australian bioscience research is widely recognised as world leading, yet our ability to commercialise discoveries and market them into global supply chains is poor.

Recent successes including the Australian vaccine Gardasil are proof positive of the quality and potential of local research, yet a question still remains as to how to successfully commercialise cutting-edge science and make it into an internationally competitive new industry for Australia’s future prosperity.

Like so many Australian bioscience discoveries, Gardasil was no accident. Ian Frazer’s cervical cancer breakthrough was built on a long heritage of pioneering work that includes Howard Florey’s penicillin development and Don Metcalf’s work on therapeutic proteins.

Join The Mandarin for a special public sector executive seminar as we explore this important initiative at 5.30 pm next Thursday 15 June at the Australian Leadership Innovation Centre in Barton, Canberra. Click here for a seminar overview. To attend please RSVP here.

Investment in science can be a long play, but there are important policy steps now being taken to accelerate momentum in Australia.

The federal government has targeted the medical technology and pharmaceuticals as a key economic and industrial growth sector and developed a major program of industry, academic and government collaboration. One of the most import developments has been a commitment for industry and government to work together through collaborative hub MTP Connect.

International models suggest Australia could quadruple its bioscience research if the policy settings are optimised. The opportunity is large, with industry estimates of 28,000 new high value jobs and $18 billion of gross value add over the next eight years if Australia can reach its potential in the biotechnology sector. 

This national opportunity is underpinned by industry estimates that the global market for medicines and vaccines is set to double over the next decade, with much of the growth coming from Asia.

The pharma sector is a truly global market. Building a sharp local understanding of the needs of this market is critical to greater commercialisation and investment. At the same time, a major strengthening of collaboration between universities and industry is expected to increase the translation of research into market ready products.

It’s  also important to recognise government and the public sector will always have a seat at the pharma table. The National Health and Medical Research Council funds much public research and its role is critical to any improvement in translational research outcomes. Recent major changes into its grant program are designed to promote innovation and to encourage early to mid career researchers.

Ensuring Australia attracts clinical trials is vital to successful local development and the focus of the government-backed growth program this year. Clinical trials support thousands of high-value jobs, but over recent times the number of clinical trials has plateaued. For Australia’s nation potential in the pharma sector to be realised,  Australia’s processes and procedures need to balance patient welfare and innovation, a challenge in a world where citizens are impatient about accessing new technologies and remedies.

Australia’s Pharmaceutical Benefits Scheme provides affordable and accessible drugs for our citizens and the design of the scheme plays a powerful role in the economic drivers of the bioscience sector. Ensuring alignment between initiatives promoting research growth and broader national health policy objectives is an important challenge. The recent landmark agreement between Medicines Australia and the federal government promises operational certainty while providing funding for new listings from price reductions for mature end-of-patent life medicines.

There are now over 50 listed medical biotechnology companies listed on the ASX and the recent launch of the $500 million Biomedical Translation Fund (BTF) provides a once-in-a-generation initiative to make Australia a global leader in the commercialisation of biomedical discoveries.

The BTF is part of the National Innovation and Science Agenda and is a for-profit venture capital fund which pools public and private capital ($250 million of Commonwealth funding to be matched with private sector capital) for investments in companies with medical research projects.

The push to have Australia be a major contributor to the surging global pharma sector is a sophisticated example of joint industry, government and academic collaboration.

  • Join The Mandarin for a special public sector executive seminar as we explore this important initiative. The seminar is scheduled for 5.30 pm next Thursday 15 June at the Australian Leadership Innovation Centre in Barton, Canberra. More details can be found here. To attend please register here. The briefing is part of our executive learning program for public sector leaders, where we seek to provide a forum for intelligent, collegiate discussion of issues of interest to government agency leaders.

 

About the author
Tom Burton

By Tom Burton

Tom Burton is the former publisher of The Mandarin. He has served in various public administration roles, specialising in the media and communications sector. He was a Walkley Award-winning journalist and executive editor of The Sydney Morning Herald. He worked as Canberra bureau chief for the Australian Financial Review and as managing editor of smh.com.au. He most recently worked at the Australian Communications and Media Authority.

Departments: Department of Health Department of Industry Innovation and Science MTP Connect Pharmaceutical Benefits Scheme

Partners: MSD

Login
Please login to comment
0 Comments
Inline Feedbacks
View all comments

The essential resource for effective
public sector professionals

Check out the Latest

By Tom Burton

Wednesday June 7, 2017
Tom Burton
Text size: A A A

Upcoming Events

14
Jul
Building Visibility + Influence for Women in the Public Sector – MASTERCLASS
29
Jul
Breakfast Briefing: Building and retaining the public sector workforce
03
Aug
Playing Bigger: Uplevelling Influence + Impact for Public Sector Leaders – ONLINE PROGRAM
15
Aug
CILT International Diploma in Logistics and Transport (Public-Sector)
15
Nov
Humanify HR Consulting – HR Leadership in Practice (HRLP)
View Calendar

Partner Content

A royal commission: Wicked problem first responder
Promoted

A royal commission: Wicked problem first responder

Data-centric, not data centres: the future of digital citizen services
Promoted

Data-centric, not data centres: the future of digital citizen services

Whitepaper: Achieving patient centricity through data-driven care
Promoted

Whitepaper: Achieving patient centricity through data-driven care

Latest Jobs


  • Chief Executive Officer, Department of the Chief Minister and Cabinet

    Northern Territory Government

    • NT CBD
    Closing date 30th July, 2022
    6 days ago Full Time - Ongoing
  • Head of Programs

    Cranlana Centre for Ethical Leadership at Monash University

    • VIC CBD
    Closing date 23rd July, 2022
    13 days ago Full Time - Fixed Term
  • General Manager Decision Support Services

    Bureau of Meteorology

    • National
    Closing date 22nd July, 2022
    14 days ago Full Time - Ongoing
  • Multiple Directors - Engagement, Partnerships and Communications

    Department of Customer Service

    • NSW CBD, Regional
    Closing date 20th July, 2022
    2 months ago Full Time - Fixed Term
  • Executive Director Digital Health

    Department of Heath (WA Health)

    • WA CBD
    Closing date 5th August, 2022
    just now Full Time - Fixed Term
  • Senior Regulatory Officer (AO7)

    Northern Territory Government

    • NT CBD
    Closing date 5th August, 2022
    just now Full Time - Ongoing
Search All Jobs

Login

Get Premium now. Not ready? Get the free Daily newsletter.

Forgot password?

Share via email

Access your 3 free Mandarin Premium articles

As part of your free trial you will receive 'The Juice', The Mandarin's daily free newsletter, the 'Premium wrap' every Saturday and marketing emails. You can opt out at any time.
The Mandarin

Get the Juice, the Mandarin’s free daily newsletter

istanbul escort
beylikdüzü escort
avcılar escort
esenyurt escort
esenyurt escort
esenyurt escort
beylikdüzü escort
avcılar escort
beylikdüzü escort
marmaris escort
izmit escort
bodrum escort
antalya escort
antalya escort bayan

You’ll also receive special offers from our partners. You can opt out any time.
Content
  • News
  • Research Series
  • Features
  • Portfolios
  • Jurisdictions
  • New Zealand
  • People & Capability
  • Thought Leadership
  • Editors’ Picks
  • Resource Library
  • Site Map
Products & Services
  • The Juice Newsletter
  • Partner & Advertising solutions
  • Mandarin Live
  • Public Sector Events Calendar
  • Partner Content
  • Premium
  • Careers
Legal
  • Privacy Policy
  • Terms of Usage
  • Code of Conduct
Connect
  • About Us
  • Contact Us
  • Support
  • Our Team
Social
Copyright © The Mandarin
Private Media logo CRIKEY SMARTCOMPANY
wpDiscuz